头颈部癌症患者淋巴水肿症状评估量表的初步研制。
Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.
机构信息
School of Nursing, Vanderbilt University, 461 21st Ave. South, 600B Godchaux Hall, Nashville, TN 37240, USA.
出版信息
Support Care Cancer. 2012 Aug;20(8):1911-8. doi: 10.1007/s00520-011-1294-6. Epub 2011 Nov 10.
PURPOSE
Currently, no instruments are available to assess symptoms secondary to lymphedema in patients with head and neck cancer (HNC). The study aim was to develop and conduct preliminary tests of such an instrument.
METHODS
A preliminary item pool was generated from a literature review, previous work in breast cancer-related lymphedema, and an observational study. The item pool was revised based on an expert panel's suggestions and feedback from 18 patients with HNC. The current questionnaire, the Lymphedema Symptom Intensity and Distress Survey-Head and Neck (LSIDS-H&N), was then pilot tested in 30 patients with HNC.
RESULTS
Preliminary testing (1) demonstrated feasibility, readability, and ease of use of the LSIDS-H&N and (2) identified that there was a considerable level of symptom burden in the cohort of patients in the piloting sample.
CONCLUSION
Content validity of the LSIDS-H&N was supported by the expert panel during development of the LSIDS-H&N. Further testing is ongoing.
目的
目前，尚无工具可用于评估头颈部癌症（HNC）患者继发于淋巴水肿的症状。本研究旨在开发并初步测试此类工具。
方法
从文献复习、乳腺癌相关淋巴水肿的先前工作和观察性研究中生成初步的项目池。根据专家小组的建议和 18 名 HNC 患者的反馈，对项目池进行了修订。然后，将当前问卷，即淋巴水肿症状强度和困扰调查-头颈部（LSIDS-H&N），在 30 名 HNC 患者中进行了试点测试。
结果
初步测试（1）表明 LSIDS-H&N 具有可行性、可读性和易用性，（2）确定在试点样本的患者队列中存在相当程度的症状负担。
结论
在 LSIDS-H&N 的开发过程中，专家小组支持 LSIDS-H&N 的内容效度。正在进行进一步的测试。
Zotero 插件